Schedule 13G ownership disclosure
KARYOPHARM THERAPEUTICS INC
Security class unavailable · CUSIP: 48576U106
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 999,275
- Percent of class
- 3.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-008029
- Form type
- SC 13G
- Filer
- Foresite Capital Fund I, L.P.
- CIK
- CIK 1562157
- Filed
- Feb 11, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership